UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1917-1923

2006

Volltextzugriff (PDF)

Phase II Trial of Irinotecan in Children With Refractory Solid Tumors: A Children's Oncology Group Study

Journal of clinical oncology, 2007-10, Vol.25 (29), p.4622-4627

2007

Volltextzugriff (PDF)

A Phase 1 Study of the Proteasome Inhibitor Bortezomib in Pediatric Patients with Refractory Leukemia: a Children's Oncology Group Study

Clinical cancer research, 2007-03, Vol.13 (5), p.1516-1522

2007

Volltextzugriff (PDF)

Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge

Pediatric blood & cancer, 2013-09, Vol.60 (9), p.1503-1506

2013

Volltextzugriff (PDF)

A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia

Blood, 2011-07, Vol.118 (1), p.28-36

2011

Volltextzugriff (PDF)

Antithrombotic Therapy in a Prospective Trial of a Pediatric Ventricular Assist Device

ASAIO journal (1992), 2016-11, Vol.62 (6), p.719-727

2016

Volltextzugriff (PDF)

The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology Group

Clinical pharmacokinetics, 2019-07, Vol.58 (7), p.899-910

2019

Volltextzugriff (PDF)

Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group

Pediatric blood & cancer, 2021-12, Vol.68 (12), p.e29333-n/a

2021

Volltextzugriff (PDF)

Response to warfarin therapy in obese pediatric patients dosed according to institutional guidelines

Journal of pediatric hematology/oncology, 2014-11, Vol.36 (8), p.e487-e489

2014

Volltextzugriff (PDF)

Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study

Cancer chemotherapy and pharmacology, 2009-07, Vol.64 (2), p.243-251

2009

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Thalidomide With Carboplatin in Children With Cancer

Journal of clinical oncology, 2004-11, Vol.22 (21), p.4394-4400

2004

Volltextzugriff (PDF)

Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia

Cancer chemotherapy and pharmacology, 2007-06, Vol.59 (6), p.847-853

2007

Volltextzugriff (PDF)

Phase I trial of irofulven (MGI 114) in pediatric patients with solid tumors

Pediatric Blood & Cancer, 2006-08, Vol.47 (2), p.163-168

2006

Volltextzugriff (PDF)

Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge: Pediatric Readmissions for Warfarin Bleeding

Pediatric blood & cancer, 2013-09, Vol.60 (9), p.1503-1506

2013

Volltextzugriff (PDF)

Lymphoid malignancies following kawasaki disease

American journal of hematology, 1995-12, Vol.50 (4), p.299-300

1995

Volltextzugriff (PDF)

Pediatrics

Clinical and Translational Science: Principles of Human Research, 2009, p.497-507

2009

Volltextzugriff (PDF)

Chapter 33 - Pediatrics

Clinical and Translational Science, 2009, p.497-507

2009

Volltextzugriff (PDF)

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children

Blood, 2020-02, Vol.135 (7), p.491-504

2020

Volltextzugriff (PDF)

Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease

Journal of the American Heart Association, 2024-02, Vol.13 (4), p.e028957-e028957

2024

Volltextzugriff (PDF)

Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials

Thrombosis and haemostasis, 2022-09, Vol.122 (9), p.1573-1583

2022

Volltextzugriff (PDF)

Preponderance of Thiopurine S-Methyltransferase Deficiency and Heterozygosity Among Patients Intolerant to Mercaptopurine or Azathioprine

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2293-2301

2001

Volltextzugriff (PDF)

Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism

Journal of thrombosis and haemostasis, 2021-05, Vol.19 (5), p.1259-1270

2021

Volltextzugriff (PDF)

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

Blood, 2020-11, Vol.136 (Supplement 1), p.35-36

2020

Volltextzugriff (PDF)

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Blood, 2020-11, Vol.136 (Supplement 1), p.24-25

2020

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(32)
Buchkapitel
(4)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(22)
Male
(21)
Female
(19)
Child
(18)
Adolescent
(14)
Child, Preschool
(14)
Oncology
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Hematology
(12)
Infant
(12)
Pediatrics
(12)
Adult
(8)
Hematologic And Hematopoietic Diseases
(6)
Pharmacokinetics
(6)
Treatment Outcome
(6)
Cardiovascular System & Cardiology
(5)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

Phase II Trial of Irinotecan in Children With Refractory Solid Tumors: A Children's Oncology Group Study

A Phase 1 Study of the Proteasome Inhibitor Bortezomib in Pediatric Patients with Refractory Leukemia: a Children's Oncology Group Study

Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge

A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia

Antithrombotic Therapy in a Prospective Trial of a Pediatric Ventricular Assist Device

The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology Group

Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group

Response to warfarin therapy in obese pediatric patients dosed according to institutional guidelines

Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study

Phase I and Pharmacokinetic Study of Thalidomide With Carboplatin in Children With Cancer

Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia

Phase I trial of irofulven (MGI 114) in pediatric patients with solid tumors

Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge: Pediatric Readmissions for Warfarin Bleeding

Lymphoid malignancies following kawasaki disease

Pediatrics

Chapter 33 - Pediatrics

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children

Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group

Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease

Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials

Preponderance of Thiopurine S-Methyltransferase Deficiency and Heterozygosity Among Patients Intolerant to Mercaptopurine or Azathioprine

Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Suchergebnisse filtern